A recent (2013) study found that high cholesterol and LDL-cholesterol levels in subjects over 50 years was associated with lowered all-cause mortality.
The Cochrane Collaboration, an independent group that is not associated with Big Pharma money stated, “Statins do not have a proven net health benefit in primary prevention populations and thus when used in that setting do not represent good use of scarce health care resources.” (1)
A recent (2013) study found that high cholesterol and LDL-cholesterol levels in subjects over 50 years was associated with lowered all-cause mortality. (2) Compared to those with cholesterol <190mg/dL, those aged 60-70 years with a cholesterol level from 190-230mg/dL had a 32% lowered mortality rate. Those with a cholesterol level from 230-308mg/dL had a 33% reduced mortality rate. For male subjects with a cholesterol over 308mg/dL, there was an insignificant 2% increase risk for all-cause mortality. Women fared better. Compared to those with a cholesterol of less than 190mg/dL, women with cholesterol levels from 190-308mg/dL had a 41-43% reduction in all-cause mortality. Similarly to men, cholesterol levels over 308mg/dL had an insignificant (2%) rise in all-cause mortality.
Folks, this study is nothing new. Low cholesterol levels are associated with an increased risk of cancer, neurological disorders and muscle disorders. There are many studies showing increased longevity in older people (over 59 years old) who have higher cholesterol levels. Keep in mind that cholesterol is needed by every cell in the body to optimally function.